232 related articles for article (PubMed ID: 26827793)
1. Inherited PTEN mutations and the prediction of phenotype.
Leslie NR; Longy M
Semin Cell Dev Biol; 2016 Apr; 52():30-8. PubMed ID: 26827793
[TBL] [Abstract][Full Text] [Related]
2. Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes.
Spinelli L; Black FM; Berg JN; Eickholt BJ; Leslie NR
J Med Genet; 2015 Feb; 52(2):128-34. PubMed ID: 25527629
[TBL] [Abstract][Full Text] [Related]
3. Biomarker May Predict Cancer Versus Autism Risk in Pten Hamartoma Tumor Syndrome: Decreased levels of fumarate were more strongly associated with autism than cancer in persons with PTEN mutations.
Am J Med Genet A; 2020 Jan; 182(1):7-8. PubMed ID: 31825175
[No Abstract] [Full Text] [Related]
4. Balancing Proliferation and Connectivity in PTEN-associated Autism Spectrum Disorder.
Tilot AK; Frazier TW; Eng C
Neurotherapeutics; 2015 Jul; 12(3):609-19. PubMed ID: 25916396
[TBL] [Abstract][Full Text] [Related]
5. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
6. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Marsh DJ; Coulon V; Lunetta KL; Rocca-Serra P; Dahia PL; Zheng Z; Liaw D; Caron S; Duboué B; Lin AY; Richardson AL; Bonnetblanc JM; Bressieux JM; Cabarrot-Moreau A; Chompret A; Demange L; Eeles RA; Yahanda AM; Fearon ER; Fricker JP; Gorlin RJ; Hodgson SV; Huson S; Lacombe D; Eng C
Hum Mol Genet; 1998 Mar; 7(3):507-15. PubMed ID: 9467011
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes.
Rodríguez-Escudero I; Oliver MD; Andrés-Pons A; Molina M; Cid VJ; Pulido R
Hum Mol Genet; 2011 Nov; 20(21):4132-42. PubMed ID: 21828076
[TBL] [Abstract][Full Text] [Related]
8. Imaging of PTEN-related abnormalities in the central nervous system.
Dhamija R; Hoxworth JM
Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175
[TBL] [Abstract][Full Text] [Related]
9. Toward Systems Pathology for PTEN Diagnostics.
Haddadi N; Travis G; Nassif NT; Simpson AM; Marsh DJ
Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31615872
[TBL] [Abstract][Full Text] [Related]
10. Clinical presentation of PTEN mutations in childhood in the absence of family history of Cowden syndrome.
Busa T; Milh M; Degardin N; Girard N; Sigaudy S; Longy M; Olshchwang S; Sobol H; Chabrol B; Philip N
Eur J Paediatr Neurol; 2015 Mar; 19(2):188-92. PubMed ID: 25549896
[TBL] [Abstract][Full Text] [Related]
11. PTEN hamartoma tumor syndrome.
Mester J; Charis E
Handb Clin Neurol; 2015; 132():129-37. PubMed ID: 26564076
[TBL] [Abstract][Full Text] [Related]
12. First report of ovarian dysgerminoma in Cowden syndrome with germline PTEN mutation and PTEN-related 10q loss of tumor heterozygosity.
Cho MY; Kim HS; Eng C; Kim DS; Kang SJ; Eom M; Yi SY; Bronner MP
Am J Surg Pathol; 2008 Aug; 32(8):1258-64. PubMed ID: 18594467
[TBL] [Abstract][Full Text] [Related]
13. Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes.
Pezzolesi MG; Li Y; Zhou XP; Pilarski R; Shen L; Eng C
Am J Hum Genet; 2006 Nov; 79(5):923-34. PubMed ID: 17033968
[TBL] [Abstract][Full Text] [Related]
14. Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.
Orloff MS; Eng C
Oncogene; 2008 Sep; 27(41):5387-97. PubMed ID: 18794875
[TBL] [Abstract][Full Text] [Related]
15. Clinical Implications for Germline PTEN Spectrum Disorders.
Ngeow J; Sesock K; Eng C
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):503-517. PubMed ID: 28476234
[TBL] [Abstract][Full Text] [Related]
16. PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Marsh DJ; Kum JB; Lunetta KL; Bennett MJ; Gorlin RJ; Ahmed SF; Bodurtha J; Crowe C; Curtis MA; Dasouki M; Dunn T; Feit H; Geraghty MT; Graham JM; Hodgson SV; Hunter A; Korf BR; Manchester D; Miesfeldt S; Murday VA; Nathanson KL; Parisi M; Pober B; Romano C; Eng C
Hum Mol Genet; 1999 Aug; 8(8):1461-72. PubMed ID: 10400993
[TBL] [Abstract][Full Text] [Related]
17. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
[TBL] [Abstract][Full Text] [Related]
18. Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN.
Busch RM; Srivastava S; Hogue O; Frazier TW; Klaas P; Hardan A; Martinez-Agosto JA; Sahin M; Eng C;
Transl Psychiatry; 2019 Oct; 9(1):253. PubMed ID: 31594918
[TBL] [Abstract][Full Text] [Related]
19. PTEN-opathies: from biological insights to evidence-based precision medicine.
Yehia L; Ngeow J; Eng C
J Clin Invest; 2019 Feb; 129(2):452-464. PubMed ID: 30614812
[TBL] [Abstract][Full Text] [Related]
20. A pathogenic role for germline PTEN variants which accumulate into the nucleus.
Mingo J; Rodríguez-Escudero I; Luna S; Fernández-Acero T; Amo L; Jonasson AR; Zori RT; López JI; Molina M; Cid VJ; Pulido R
Eur J Hum Genet; 2018 Aug; 26(8):1180-1187. PubMed ID: 29706633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
